The cells in your body are brimming with regenerative potential. Together, your cells and our cells may be able to reduce or eliminate your pain, regenerate your tissue, and revive the range of movement you may have thought you’d lost permanently.
Unlike surgery, which removes tissue and bone from your body, regenerative medicine harvests live cells. These are injected directly into your pain site, stimulating your own cells to regenerate themselves.
Depending on your age, body type, genetics, and injury severity, the live nucleated cells we deliver to your tissue may continue producing human growth factors for weeks, sometimes even months. As with all medical procedures, success rates will also vary depending on all these factors.
Injured cells in your skin, bones, muscles, ligaments, tendons, and connective joints send out signals. Stem cells respond to those signals, migrate, to the injured tissue, and release proteins that nourish and stimulate your own cells to begin regenerating.
Once your practitioner injects them, Liveyon’s cells dock next to your cells and release growth factors, cytokines, and chemokines, which then may:
Liveyon processes the umbilical cord blood of healthy newborns. If a pregnant woman scheduled for cesarean section decides she does not want to keep and store her unborn child’s umbilical cord, her OB/GYN asks whether she would like to donate it. After she signs an informed consent form, a medical and social history review is conducted, as well as a blood test.
If the new mother meets all donor eligibility requirements, she is accepted as a donor. After her baby is born, the umbilical cord blood is collected in a sterile collection bag and sent to a lab.
The cord blood is processed within 48 hours using proprietary methods. A sample of the finished product is tested by an independent third-party lab for sterility. Only after all lab reports have passed the regulatory requirements can the umbilical cord stem cells be distributed.
Stem cell products have the potential to treat a vast number of medical conditions. They’re already becoming a common alternative to risky, expensive surgeries in orthopedics, especially sports medicine, which has been treating athletes with regenerative therapies for over 20 years. However, the science demonstrating the benefits and safety behind each of these products is still in developmental stages.
That being said, thousands of studies around the world have demonstrated positive outcomes of stem cell use and show that stem cells derived from the umbilical cord are able to regulate our immune system more effectively than stem cells derived from bone marrow or fat.
Liveyon’s stem cell product has been used successfully by practitioners all across the globe. Before embarking on any stem cell therapy, however, you should consult the clinical trials on the national health databases and always seek the advice of your healthcare provider.
The FDA recently confirmed there is only one registered and approved stem cell product on the market: umbilical cord blood-derived hematopoietic progenitor cells (blood-forming stem cells) used for certain indications. While there is enormous promise in stem cell therapies, and thousands of ongoing experiments trying to establish efficacy, stem cell treatments do not yet meet the FDA’s scientific approval standard.
Practitioners tapping into this enormous promise of stem cells for any therapeutic use must exercise their professional judgment and expertise. We urge anyone embarking on the use of stem cell therapies to consult the national health databases to evaluate current clinical trial information, and the FDA’s website on human tissue, to get its current therapy evaluations.
In 2018 the FDA’s commissioner and research director reported that the agency will be incorporating some “new concepts for how small investigators and firms can seek and meet the approval standard for products through efficient expedited pathways.” You can keep up with the latest developments on the FDA’s website.
Worldwide clinical research and experience over almost 20 years have given us some effective parameters for various types of injury. After examining and assessing the nature and severity of your injury, medical history, and general health, your Liveyon provider will decide how many million cells are needed for fast, effective treatment.
It is not uncommon to have an inflammatory response after a stem cell injection. This is not because your body is rejecting the cells. It may actually be a positive sign that the live cells are creating a healing response.
The degree of inflammatory response to our live nucleated cells can vary based on:
As with any other injection procedure, there is a small risk of bacterial infection not associated with the injected cells. If you experience severe pain, bleeding, or swelling at your injection site, or if you experience fever, nausea, dizziness, vomiting, or any other concerning symptoms, don’t wait—call your medical provider or seek emergency medical care right away.
You may be given a small amount of local anesthetic to numb the needle pathway on your skin. However, your Liveyon provider will not apply large amounts of local anesthetic into the area being treated. Studies have shown that doing so may damage the nucleated cells.
Pain relief typically begins immediately after your treatment. Regeneration time varies depending on the severity of your injury and your ability to follow post-treatment care instructions, along with your rehabilitation program to strengthen affected areas.
It’s well worth the wait, though. Our trained and experienced Liveyon providers have already saved countless pain-plagued patients from risky, expensive surgeries and procedures. Now they’re prepared to customize a stem cell regeneration plan for you.